Is an AI-powered digital future much closer than the animal health industry believes? Our EVP, CDO & CTO, Group President China, Brazil & Precision Animal Health, Wafaa Mamilli thinks so. Wafaa recently spoke with Joseph Harvey from S&P Global and called on the industry to accelerate digital, data and #AI innovation. She pointed out that to unlock the full value of digital, the animal health industry must: -Accelerate data standardization and develop platforms for the exchange of information -Advance digital fluency across the sector’s value chain. -Maintain a "laser focus" on user experience and adoption - from colleagues to customers. 👉 Swipe through below for more of her insights. Full article: https://lnkd.in/eju2-SCA #AnimalHealth #Digital
Zoetis
Pharmaceutical Manufacturing
Parsippany, NJ 432,023 followers
Nurturing our world and humankind by advancing care for animals
About us
The world’s leading animal health company. Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. We’ve been innovating ways to predict, prevent, detect, and treat animal illness for over 70 years, and we continue to stand by those raising and caring for animals worldwide – from veterinarians and pet owners to livestock farmers. Our leading portfolio and pipeline of medicines, vaccines, diagnostics and technologies make a difference in over 100 countries. Community Guidelines: This page is intended for learning more about how Zoetis is advancing care for animals. We aspire to create a supportive community, but there are some guidelines to which posts and comments on this page must adhere. If your post references a side effect related to any Zoetis product, we may contact you for more information. To monitor the safety of Zoetis products, we advise you to call our Veterinary Medical Information and Product Support Team at 1-888-963-8471; Support Team is available Mon-Fri 9am to 6:30pm ET. We reserve the right to remove any post/comment that violates LinkedIn Guidelines. We respectfully request that you refrain from posting comments including: Unsolicited and/or unverified medical advice Vulgarity and/or profanity Discriminatory and/or derogatory comments, hate speech Politics and religion Personal attacks and/or threats Promotion of illegal activity Copyright/trademark infringements Topics that may be considered spam/advertising Our regular business hours are Mon-Fri 9am to 5pm ET. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information shared is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use
- Website
-
http://www.zoetis.com
External link for Zoetis
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Parsippany, NJ
- Type
- Public Company
- Founded
- 2013
Locations
-
Primary
10 Sylvan Way
Parsippany, NJ 07054, US
-
Mercuriusstraat 20
Zaventem, Flemish Region 1930, BE
Employees at Zoetis
Updates
-
Since 2020, we have been proud to partner with INROADS a leader in developing high school and college students from underrepresented communities. Our partnership has allowed us to engage INROADS scholars, creating pathways and equitable opportunities in the workplace through our internship program, immersive educational experiences and even welcoming students as full-time colleagues upon graduation. Our colleagues recently joined INROADS at their Founder’s Day Benefit Gala to celebrate their mission that also raised important funds for thousands of diverse high school and college students from across the U.S. to participate in mentorship programs, leadership training, coaching and career readiness. We are excited to continue our partnership and for the opportunity to introduce students to the animal health industry this summer through our Zoetis Internship Program! #AnimalHealth
-
We are proud to be named to Fair360’s (formerly DiversityInc.) Top 50 Companies list for the first time! This recognition demonstrates our progress and sustained commitment to advancing Diversity, Equity and Inclusion. In addition to the Top 50 recognition, Zoetis was also recognized on three specialty lists, including Top Companies for Women Executives, Top Companies for Latino Executives and Top Companies for Talent Acquisition for Women of Color. We know that every colleague plays a role in leading with inclusion to embrace diversity and create equity. https://lnkd.in/ep5Ntftu #ZoetisProud #DiversityEquityAndInclusion
-
We’re excited to announce that Ester Banque, our EVP and President of U.S. Operations, has been elected Board Chair of the Animal Health Institute (AHI). During Ester’s term, she will serve as a leading voice in animal health policy, innovation and research to drive the development of the medicines that help our pets live longer, healthier lives, and contribute to safe and sustainable food by keeping livestock animals healthy. This opportunity further affirms our leadership in the continuously evolving animal health field, and we hope you’ll join us in congratulating Ester for her election! Read more about Ester’s election and the work of the AHI here: https://lnkd.in/eKtAk8it #AnimalHealthPolicy #Innovation #AnimalHealth
-
ICYMI: We recently shared our first quarter financial results. Our strong growth was fueled by the innovative franchises in our companion animal portfolio. Learn more here: https://lnkd.in/eGKYwaNC #Earnings #AnimalHealth
-
We are thrilled to announce that Zoetis Spain has achieved a 2024 Great Place To Work Spain certification! A whopping 81% of colleagues in Spain voiced that Zoetis is an excellent place to work, proving that our colleagues make the difference. We're so proud of our team’s dedication to fostering an inclusive workplace where all colleagues can thrive. #Zoetisproud #GPTWcertifiedES #GPTWcertified
-
It's critical to ensure veterinary healthcare teams have fast, accurate test results so they have valuable time back to do what they love most – caring for animals. That’s why we’ve expanded our multi-application diagnostics platform to include AI Urine Sediment analysis. Read more about the game-changing technology here: https://lnkd.in/eAHfZ589 #AnimalHealth #VeterinaryMedicine
-
The Zoetis Foundation and the American Association of Bovine Practitioners Foundation (AABPF) are excited to share that applications are now open for the 2024 Student Scholarship Program. The Zoetis Foundation is funding 16 scholarships worth $7,500 each, benefiting veterinary students pursuing careers in bovine practice. Through the scholarship program, the Zoetis Foundation is supporting exceptional veterinary students dedicated to bovine practice. Learn more about the scholarship’s eligibility criteria and apply by May 31, 2024, here: https://lnkd.in/dtFn7GQW #VeterinaryStudent #Scholarships 📷 2023 scholarship recipients
Zoetis Foundation/AABP Foundation 2024 Student Scholarship Program
aabp.org
-
We had a strong first quarter thanks to our talented colleagues, diverse portfolio and global scale. Learn more about our Q1 financial results: https://lnkd.in/eGfY7vKc #Earnings #AnimalHealth
-
Throughout 2023, we continued to develop meaningful relationships with customers and meet their needs for animal health products. We completed expansions at our manufacturing facilities in Lincoln, Nebraska, and in Tullamore, Ireland, to support the growth of our mAb production. We also expanded our R&D capabilities at our Durham, North Carolina, facility to help transform the diagnostics industry and provide our customers with new and better diagnostic solutions to support animal health. Learn more about how we deliver an exceptional customer experience in our 2023 Annual Report: https://lnkd.in/eaZdrb2b #Innovation #AnnualReport #AnimalHealth
Zoetis 2023 Annual Report
investor.zoetis.com
Affiliated pages
Similar pages
Browse jobs
Stock
ZTS
NYSE
20 minutes delay
$174.06
0.35 (0.202%)
- Open
- 174.05
- Low
- 172.58
- High
- 174.66
Data from Refinitiv
See more info on